Evidence-based Canadian guidelines for tele-retina screening for diabetic retinopathy: recommendations from the Canadian Retina Research Network (CR2N) Tele-Retina Steering Committee



      The purpose of this report is to develop a consensus for Canadian national guidelines specific to a tele-medicine approach to screening for diabetic retinopathy (DR) using evidence-based and clinical data.


      Canadian Tele-Screening Grading Scales for DR and diabetic macular edema (DME) were created primarily based on severity grading scales outlined by the International Clinical Diabetic Retinopathy Disease Severity Scale (ICDR) and the Scottish DR Grading Scheme 2007. Other grading scales used in international screening programs and the clinical expertise of the Canadian Retina Research Network members and retina specialists nationwide were also used in the creation of the guidelines.


      National Tele-Screening Guidelines for DR and DME with and without optical coherence tomography (OCT) images are proposed. These outline a diagnosis and management algorithm for patients presenting with different stages of DR and/or DME. General guidelines detailing the requirements for imaged retina fields, image quality, quality control, and follow-up care and the role of visual acuity, pupil dilation, OCT, ultra-wide-field imaging, and artificial intelligence are discussed.


      Tele-retina screening can help to address the need for timely and effective screening for DR, whose prevalence continues to rise. A standardized and evidence-based national approach to DR tele-screening has been proposed, based on DR/DME grading using two 45° image fields or a single widefield or ultra-wide-field image, preferable use of OCT imaging, and a focus on local quality control measures.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Canadian Journal of Ophthalmology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


      1. Diabetes Canada [Internet]. Toronto: Canadian Diabetes Association; c2018. [cited 2018 Oct]. Available from:

        • Frank R.N.
        Diabetic retinopathy.
        N Engl J Med. 2004; 350: 48-58
        • Hirai F.E.
        • Tielsch J.M.
        • Klein B.E.K.
        • Klein R.
        Ten-year change in vision-related quality of life in type 1 diabetes: Wisconsin Epidemiologic Study of Diabetic Retinopathy.
        Ophthalmology. 2011; 118: 353-358
        • Javitt J.C.
        • Canner J.K.
        • Sommer A.
        Cost effectiveness of current approaches to the control of retinopathy in type I diabetics.
        Ophthalmology. 1989; 96: 255-264
        • Whited J.D.
        Accuracy and reliability of teleophthalmology for diagnosing diabetic retinopathy and macular edema: a review of the literature.
        Diabetes Technol Ther. 2006; 8: 102-111
        • William G.A.
        • Scott I.U.
        • Haller J.A.
        • Maguire A.M.
        • Marcus D.
        • McDonald H.R.
        Single-field fundus photography for diabetic retinopathy screening: a report by the American Academy of Ophthalmology.
        Ophthalmology. 2004; 111: 1055-1062
        • Murgatroyd H.
        • Ellingford A.
        • Cox A.
        • et al.
        Effect of mydriasis and different field strategies on digital image screening of diabetic eye disease.
        Br J Ophthalmol. 2004; 88: 920-924
        • Ting D.S.
        • Tay-Kearney M.L.
        • Kanagasingam Y.
        Light and portable novel device for diabetic retinopathy screening.
        Clin Exp Ophthalmol. 2012; 40: e40-e46
        • Vujosevic S.
        • Benetti E.
        • Massignan F.
        • et al.
        Screening for diabetic retinopathy: 1 and 3 nonmydriatic 45-degree digital fundus photographs vs 7 standard early treatment diabetic retinopathy study fields.
        Am J Ophthalmol. 2009; 148: 111-118
        • Aptel F.
        • Denis P.
        • Rouberol F.
        • Thivolet C.
        Screening of diabetic retinopathy: effect of field number and mydriasis on sensitivity and specificity of digital fundus photography.
        Diabetes Metab. 2008; 34: 290-293
        • Pugh J.A.
        • Jacobson J.M.
        • Van Heuven W.A.
        • et al.
        Screening for diabetic retinopathy: the wide-angle retinal camera.
        Diabetes Care. 1993; 16: 889-895
        • Ku J.J.
        • Landers J.
        • Henderson T.
        • Craig J.E.
        The reliability of single-field fundus photography in screening for diabetic retinopathy: the Central Australian Ocular Health Study.
        Med J Aust. 2013; 198: 93-96
        • Lin D.Y.
        • Blumenkranz M.S.
        • Brothers R.J.
        • Grosvenor J.M.
        The sensitivity and specificity of single-field nonmydriatic monochromatic digital fundus photography with remote image interpretation for diabetic retinopathy screening: a comparison with ophthalmoscopy and standardized mydriatic color photography.
        Am J Ophthalmol. 2002; 134: 204-213
        • Olson J.A.
        • Strachan F.M.
        • Hipwell J.H.
        • et al.
        A comparative evaluation of digital imaging, retinal photography and optometrist examination in screening for diabetic retinopathy.
        Diabet Med. 2003; 20: 528-534
        • Boucher M.C.
        • Gresset J.A.
        • Angioi K.
        • Olivier S.
        Effectiveness and safety of screening for diabetic retinopathy with two nonmydriatic digital images compared with the seven standard stereoscopic photographic fields.
        Can J Ophthalmol. 2003; 38: 557-568
        • Scanlon P.H.
        • Stratton I.M.
        • Histed M.
        • Chave S.J.
        • Aldington S.J.
        The influence of background diabetic retinopathy in the second eye on rates of progression of diabetic retinopathy between 2005 and 2010.
        Acta Ophthalmol. 2013; 91: e335-e339
        • Perrier M.
        • Boucher M.C.
        • Angioi K.
        • Gresset J.A.
        • Olivier S.
        Comparison of two, three and four 45 degree image fields obtained with the Topcon CRW6 nonmydriatic camera for screening for diabetic retinopathy.
        Can J Ophthalmol. 2003; 38: 569-574
      2. Scottish Diabetic Retinopathy Screening Collaborative [Internet]. Scotland; c2003 [cited 2018 Oct]. Available from:

        • Yogesan K.
        • Constable I.J.
        • Barry C.J.
        • Eikelboom R.J.
        • McAllister I.L.
        • Tay-Kearney M.L.
        Telemedicine screening of diabetic retinopathy using a hand-held fundus camera.
        Telemed J. 2000; 6: 219-223
        • Nunes S.
        • Pereira I.
        • Snatos A.
        • Bernardes R.
        • Cunha-Vaz J.
        Central retinal thickness measured with HD-OCT shows a weak correlation with visual acuity in eyes with CSME.
        Br J Ophthalmol. 2010; 94: 1201-1204
        • Scanlon P.H.
        • Foy C.
        • Chen F.K.
        Visual acuity measurement and ocular co-morbidity in diabetic retinopathy screening.
        Br J Ophthalmol. 2008; 92: 775-778
        • Corcoran J.S.
        • Moore K.
        • Agarawal O.P.
        • Edgar D.F.
        • Yudkin J.S.
        Visual acuity screening for diabetic maculopathy.
        Prac Diabetes Int. 1985; 2: 230-232
        • Scanlon P.H.
        The English National Screening Programme for diabetic retinopathy 2003–2016.
        Acta Diabetol. 2017; 54: 515-525
        • Boucher M.C.
        • El Yamani M.E.M.
        Urban diabetic retinopathy teleophthalmology screening: results and impact at the service corridor.
        Can J Ophthalmol. 2019; 54: 359-366
        • Scanlon P.H.
        • Malhotra R.
        • Thomas G.
        • et al.
        The effectiveness of screening for diabetic retinopathy by digital imaging photography and technician ophthalmoscopy.
        Diabet Med. 2003; 20: 467-474
        • Scanlon P.H.
        • Malhotra R.
        • Greenwood R.H.
        • et al.
        Comparison of two reference standards in validating two field mydriatic digital photography as a method of screening for diabetic retinopathy.
        Br J Ophthalmol. 2003; 87: 1258-1263
        • Scanlon P.H.
        • Foy C.
        • Malhotra R.
        • Aldington S.J.
        The influence of age, duration of diabetes, cataract, and pupil size on image quality in digital photographic retinal screening.
        Diabetes Care. 2005; 28: 2448-2453
        • Liew G.
        • Mitchell P.
        • Wang J.J.
        • Wong T.Y.
        Fundoscopy: to dilate or not to dilate?.
        BMJ. 2006; 332: 3
        • Pandit R.J.
        • Taylor R.
        Mydriasis and glaucoma: exploding the myth—a systematic review.
        Diabet Med. 2000; 17: 693-699
        • Massin P.
        • Girach A.
        • Erginay A.
        • Gaudric A.
        Optical coherence tomography: a key to the future management of patients with diabetic macular oedema.
        Acta Ophthalmol Scand. 2006; 84: 466-474
        • Stanga P.E.
        • Bird A.C.
        Optical coherence tomography (OCT): principles of operation, technology, indications in vitreoretinal imaging and interpretation of results.
        Int Ophthalmol. 2001; 23: 191-197
        • Goebel W.
        • Kretzchmar-Gross T.
        Retinal thickness in diabetic retinopathy: a study using optical coherent tomography (OCT).
        Retina. 2002; 22: 759-767
        • Bressler N.M.
        • Edwards A.R.
        • Antoszyk A.N.
        • et al.
        Retinal thickness on Stratus optical coherence tomography in people with diabetes and minimal or no diabetic retinopathy.
        Am J Ophthalmol. 2008; 145: 894-901
        • Felfeli T.
        • Alon R.
        • Merritt R.
        • Brent M.H.
        Toronto tele-retinal screening program for detection of diabetic retinopathy and macular edema.
        Can J Ophthalmol. 2019; 54: 203-211
        • Prescott G.
        • Sharp P.
        • Goatman K.
        • et al.
        Improving the cost-effectiveness of photographic screening for diabetic macular oedema: a prospective, multi-centre, UK study.
        Br J Ophthalmol. 2014; 98: 1042-1049
        • Olson J.
        • Sharp P.
        • Goatman K.
        • et al.
        Improving the economic value of photographic screening for optical coherence tomography-detectable macular oedema: a prospective, multicentre, UK study.
        Health Technol Assess. 2013; 17: 1-142
        • Vitgili G.
        • Menchini F.
        • Casazza G.
        • et al.
        Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy.
        Cochrane Database Sys Rev. 2015; 1CD008081
        • Wang Y.T.
        • Tadarati M.
        • Wolfson Y.
        • Bressler S.B.
        • Bressler N.M.
        Comparison of prevalence of diabetic macular edema based on monocular fundus photography vs optical coherence tomography.
        JAMA Ophthalmol. 2016; 134: 222-228
        • Dodson P.M.
        • Quant L.
        • Leigh R.
        • Wharton H.
        Ophthalmic Photographic Diabetic Review (OPDR): a virtual clinical approach for management of referable diabetic maculopathy.
        in: Proceedings of the Birmingham, Solihull and Black Country Diabetic Eye Screening, 2012 Jul 25, Birmingham, UK2012
        • Sherifali D.
        • Rabi D.
        • McDonald C.
        • et al.
        2018 Clinical Practice Guidelines Methods.
        Can J Diabetes. 2018; 42: S6-S9
        • Choudhry N.
        • Duker J.S.
        • Freund K.B.
        • et al.
        Classification and guidelines for widefield imaging.
        Ophthalmol Retina. 2019; 3: 843-849
        • Aiello L.P.
        • Odia I.
        • Glassman A.R.
        • et al.
        Comparison of Early Treatment Diabetic Retinopathy Study Standard 7-Field Imaging with Ultrawide-Field Imaging for Determining Severity of Diabetic Retinopathy.
        JAMA Ophthalmol. 2019; 137: 65-73
        • Rasmussen M.L.
        • Broe R.
        • Frydkjaer-Olsen U.
        • et al.
        Comparison between Early Treatment Diabetic Retinopathy Study 7-field retinal photos and non-mydriatic, mydriatic and mydriatic steered widefield scanning laser ophthalmoscopy for assessment of diabetic retinopathy.
        J Diabetes Complications. 2015; 29: 99-104
        • Silva P.S.
        • Cavallerano J.D.
        • Sun J.K.
        • Noble J.
        • Aiello L.M.
        • Aiello L.P.
        Nonmydriatic ultrawide field retinal imaging compared with dilated standard 7-field 35-mm photography and retinal specialist examination for evaluation of diabetic retinopathy.
        Am J Ophthalmol. 2012; 154: 549-559
        • Silva P.S.
        • Horton M.B.
        • Clary D.
        • Lewis D.H.
        • Sun J.K.
        • Cavallerano J.D.
        Identification of diabetic retinopathy and ungradable image rate with ultrawide field imaging in a national teleophthalmology program.
        Ophthalmology. 2016; 123: 1360-1367
        • Talks S.J.
        • Manjunath V.
        • Steel D.H.
        • Peto T.
        • Taylor R.
        New vessels detected on wide-field imaging compared to two-field and seven-field imaging: implications for diabetic retinopathy screening image analysis.
        Br J Ophthalmol. 2015; 99: 1606-1609
        • Zachariah S.
        • Wykes W.
        • Yorston
        The Scottish Diabetic Retinopathy Screening programme.
        Commun Eye Health. 2015; 28: s22-s23
        • Dutra Medeiros M.
        • Mesguita E.
        • Papoila A.L.
        • Genro V.
        • Raposo J.F.
        First diabetic retinopathy prevalence study in Portugal: RETINODIAB Study – evaluation of the screening programme for Lisbon and Tagus Valley region.
        Br J Ophthalmol. 2015; 99: 1328-1333
      3. Public Health England [Internet]. England: Government Digital Service; c2017 [cited Oct 2018]. Available from:

        • Widdowson S.
        • Rankin P.
        Updates to test and training system benefit diabetic eye screening providers [Internet].
        NHS Diabetic Eye Screening Programme, England2016 ([cited Oct 2018]. Available from:)
      4. Public Health England [Internet]. England: NHS Diabetic Eye Screening Programme; c2016 [cited Oct 2018]. Available from:

      5. Public Health England [Internet]. England: Government Digital Service; c2018 [cited Oct 2018]. Available from:

        • British Diabetic Association
        Retinal Photography Screening for Diabetic Eye Disease: A British Diabetic Association Report.
        British Diabetic Association, London1997 (C)
        • Hooper P.
        • Boucher M.C.
        • Cruess A.
        • et al.
        Canadian Ophthalmological Society Evidence-based Clinical Practice Guidelines for the Management of Diabetic Retinopathy – executive summary.
        Can J Ophthalmol. 2012; 47: 91-96
        • Horton M.B.
        • Silva P.S.
        • Cavallerano J.D.
        • Aiello L.P.
        Operational components of telemedicine programs for diabetic retinopathy.
        Curr Diab Rep. 2016; 16: 128
        • Wong T.Y.
        • Bressler N.M.
        Artificial intelligence with deep learning technology looks into diabetic retinopathy screening.
        JAMA. 2016; 316: 2366-2367
        • Ting D.S.W.
        • Tan G.S.W.
        • Agrawal R.
        • et al.
        Optical coherence tomographic angiography in type 2 diabetes and diabetic retinopathy.
        JAMA Ophthalmol. 2017; 135: 306-312
        • Gulshan V.
        • Peng L.
        • Coram M.
        • et al.
        Development and validation of a deep learning algorithm for detection of diabetic retinopathy in retinal fundus photographs.
        JAMA. 2016; 316: 2402-2410
        • Boucher M.C.
        • Desroches G.
        • Garcia-Salinas R.
        • et al.
        Teleophthalmology screening for diabetic retinopathy through mobile imaging units within Canada.
        Can J Ophthalmol. 2008; 43: 658-668
        • Ribeiro L.
        • Oliveira C.M.
        • Neves C.
        • Ramos J.D.
        • Ferreira H.
        • Cunha-Vaz J.
        Screening for diabetic retinopathy in the Central Region of Portugal: added value of automated ‘disease/no disease’ grading.
        Ophthalmologica. 2015; 233: 96-103
      6. Grzybowski A, Brona P, Lim G, et al. Artificial intelligence for diabetic retinopathy screening: a review [Epub ahead of print]. Eye. doi: 10.1038/s41433-019-0566-0, Accessed

        • Wilkinson C.P.
        • Ferris 3rd, F.L.
        • Klein R.E.
        • et al.
        Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales.
        Ophthalmology. 2003; 110: 1677-1682
        • Harding S.
        • Greenwood R.
        • Aldington S.
        • et al.
        Grading and disease management in national screening for diabetic retinopathy in England and Wales.
        Diabet Med. 2003; 20: 965-971
        • Grand M.G.
        Photocoagulation for diabetic macular edema.
        Arch Ophthalmol. 1986; 104: 1115-1116
        • Henricsson M.
        • Sellman A.
        • Tyrberg M.
        • Groop L.
        Progression to proliferative retinopathy and macular oedema requiring treatment. Assessment of the alternative classification of the Wisconsin Study.
        Acta Ophthalmol Scand. 1999; 77: 218-223
      7. American Academy of Ophthalmology [Internet]. c2002 [cited 2018 Oct]. Available from:

        • Early Treatment Diabetic Retinopathy Study Research Group
        Photocoagulation for Diabetic Macular Edema: Early Treatment Diabetic Retinopathy Study Report Number 1.
        Arch Ophthalmol. 1985; 103: 1796-1806
      8. National Health and Nutrition Examination Survery (NHANES) [Internet]. c2008 [cited 2018 Oct]. Available from:

        • Wong T.Y.
        • Klein R.
        • Islam F.M.
        • et al.
        Diabetic retinopathy in a multi-ethnic cohort in the United States.
        Am J Ophthalmol. 2006; 141: 446-455
        • Rudnisky C.J.
        • Tennant M.T.
        • de Leon A.R.
        • Hinz B.J.
        • Greve M.D.
        Benefits of stereopsis when identifying clinically significant macular edema via teleophthalmology.
        Can J Ophthalmol. 2006; 41: 727-732
        • Cunha-Vaz J.
        • Ribeiro L.
        • Costa M.
        • Simo R.
        Diabetic retinopathy phenotypes of progression to macular edema: pooled analysis from independent longitudinal studies of up to 2 years’ duration.
        Invest Ophthalmol Vis Sci. 2017; 58: BIO206-BIO210
        • Tan G.S.
        • Cheung N.
        • Simo R.
        • Cheung G.C.
        • Wong T.Y.
        Diabetic macular oedema.
        Lancet Diabetes Endocrinol. 2017; 5: 143-155
        • Gangaputra S.
        • Lovato J.F.
        • Hubbard L.
        • et al.
        Comparison of standardized clinical classification with fundus photograph grading for the assessment of diabetic retinopathy and diabetic macular edema severity.
        Retina. 2013; : 1393-1399